130
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Fast-dissolving ocular films of riboflavin acetate conjugate for treatment of keratoconus in UVA-CXL procedure: ex vivo permeation, hemolytic toxicity and apoptosis detection

, &

Bibliography

  • Spoerl E, Raiskup F. Corneal crosslinking with riboflavin A. Part II. Clinical indications and results. Ocul Surf 2012; Early Online
  • Sharma A, Nottage JM, Mirachia K, et al. Persistent corneal edema after collagen cross-linking for keratoconus. Am J Ophthalmol 2012;154:922-6
  • Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620-7
  • Anthony CM, Osseltan MD, Widdop B. Clarke's analysis of drugs and poisons. K.M. Varghese Co., Mumbai; 2004
  • Wollensak G, Iomdina E. Biochemical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg 2009;35:540-6
  • Kozobolis V, Labiris G, Gkika M, et al. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea 2010;29(2):235-8
  • Lee VHL. Mechanism and facilitation of corneal drug penetration. J Control Release 1990;11:79-90
  • Ding S. Recent developments in ophthalmic drug delivery. PSTT 1998;1:328-35
  • Bundgaard H, Burr A, Shih-Chieh C, et al. Prodrugs of timolol for improved ocular delivery: synthesis, hydrolysis kinetics and lipophilicity of various alkyl, cycloalkyl and aromatic esters of timolol. Int J Pharm 1988;46:77-88
  • Jordan CGM, Quigley JM, Timoney RF. Synthesis, hydrolysis kinetics and lipophilicity of O-acyl esters of oxprenolol. Int J Pharm 1992;84:175-89
  • Chetoni P, Saettone MF. Albuterol prodrugs for ocular administration: synthesis and evaluation of the physico-chemical and IOP-depressant properties of three albuterol triesters. Int J Pharm 1994;105:147-55
  • Niemi R, Huuskonen J, Laine K, et al. Synthesis, hydrolysis, and intraocular pressure lowering effects of fadolmidine prodrugs. Int J Pharm 2005;295:121-7
  • Sasaki H, Igarashi Y, Nishida K, Nakamura J. Ocular delivery of beta-blocker, tilisolol, through the prodrug approach. Int J Pharm 1993;93:49-60
  • Mandell AI, Stentz F, Kitabchi AE. Dipivalyl epinephrine: a new pro-drug in the treatment of glaucoma. Ophthalmology 1978;85:268-75
  • Chien DS, Tang-Liu DD, Woodward DF. Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva. J Pharm Sci 1997;86:1180-6
  • Waring GO, Hue DA. The drug science of cross-linking. J Cataract Refract Surg 2012;38:42-3
  • Dixit RP, Puthi SP. Oral strip technology: overview and future potential. J Control Release 2009;139:94-107
  • Cilurzo F, Cupone IE, Minghetti P, et al. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm 2008;70:895-900
  • Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 2004;22(1):27-105
  • Nair AB, Kumria R, Harsha S, et al. In vitro techniques to evaluate buccal films. J Control Release 2013;166:10-21
  • Sharma R, Ahuja M, Kaur H. Thiolated pectin nanoparticles: preparation, characterization and ex vivo corneal permeation study. Carbohydr Polym 2012;87:1606-10
  • Ravisankar R, Somvanshi R. Studies on long term pathological effects of bracken fern (pteridium aquilinum) in laboratory rats and hill cattle. Indian J Vet Path 2005;29:61-8
  • Sakellariou P, Rowe RC, White EFT. An evaluation of the interaction and plasticizing efficiency of the polyethylene glycols in ethyl cellulose and hydroxypropyl methylcellulose films using the torsional braid pendulum. Int J Pharm 1986;31:55-64
  • Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, et al. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS class II drug nanoparticles for pharmaceutical applications. Int J Pharm 2012;423:496-508
  • Tandale YN, Wagh VD. Formulation and evaluation of dorzolamide hydrochloride polymeric film. Int J Pharm Tech Res 2011;3:1817-24
  • Felton LA. Mechanisms of polymeric films. Int J Pharm 2013; Early online
  • Arya A, Sharma V, Pathak K. Pharmaceutical evaluation and dynamic vapor sorption studies of fast dissolving intraoral films of loratadine. Pharm Dev Tech 2013;182:1329-38
  • Llabot JM, Palma SD, Manzo RH, et al. Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation. Int J Pharm 2007;336:263-8
  • Repka MA, Gutta K, Prodduturi S, et al. Characterization of cellulosic hot melt extruded films containing lidocaine. Eur J Pharm Biopharm 2005;59:189-96
  • Wong CF, Yuen KH, Peh KK. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm 1999;178:11-22
  • Guo C, Stine KJ, Kauffman JF, et al. Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design. Eur J Pharm Biopharm 2008;35:417-26
  • Chaichi MJ, Azizi SN, Alijanpour O, et al. Application of Box-Behnken design in the optimization of new peroxyoxalate-H2O2 chemiluminescence system using furan derivatives as blue activators. J Lumin 2013;138:65-71
  • Papadopoulou K, Kalagona IM, Philippoussis A, et al. Optimization of fungal decolorization of azo and anthraquinone dyes via Box-Behnken design. Int Biodeterioration Biodegradation 2013;77:31-8
  • Maran JP, Manikandan S. Response surface modeling and optimization of process parameters for aqueous extraction of pigments from prickly pear (Opuntia ficus-indica) fruit. Dyes Pigments 2012;95:465-72
  • Pech B, Duval O, Richomme P, et al. A timolol prodrug for improved ocular delivery: synthesis, conformational study and hydrolysis of palmitoyl timolol malonate. Int J Pharm 1996;128:179-88
  • Sasaki H, Igarashi Y, Nishida K, et al. Ocular delivery of the beta-blocker, tilisolol through the prodrug approach. Int J Pharm 1993;93:49-60
  • Ostacolo C, Caruso C, Tronino D, et al. Enhancement of corneal permeation of riboflavin-5'-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment. Int J Pharm 2013;440:148-53
  • Jester JV, Li L, Molai A, et al. Extent of initial corneal injury as a basis for alternative eye irritation tests. Toxicol In Vitro 2001;15:115-30
  • Baydoun L, Furrer P, Gurny R, et al. New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance. Eur J Pharm Biopharm 2004;58:169-75
  • Furrer P, Plazonnet B, Mayer JM, et al. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int J Pharm 2000;207:89-98
  • Saarinen-Savolainen P, Jarvinen T, Suhonen P, et al. Amphiphilic properties of prodrugs. Int J Pharm 1996;133:171-8
  • Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 2005;5:1-7
  • Bonfoco E, Krainc D, Ankarcrona M, et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartame or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995;92:7162-6
  • Pitrak DL, Tsai HC, Mullane KM, et al. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest 1996;98:2714-19
  • Cho KS, Lee EH, Choi JS, et al. Reactive oxygen species-induced apoptosis and necrosis in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 1999;40:911-19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.